Osimertinib clearly activates caspase-8, which, in general as DR4 does, works upstream of Bim in EGFRm NSCLC cells and triggers the extrinsic apoptotic pathway as we previously demonstrated 35, 41. This evidence concerns the gene CASP8 and non-small cell lung carcinoma.